Gesamtlänge aller Episoden: 12 days 1 hour 39 minutes
Sifting through the 100+ episodes we've done this year about the coronavirus has given us time to reflect on what we've actually learned. And the things that are most important don't have anything to do with virology or epidemiology...
Will Germans change their Christmas plans enough to avert a coronavirus catastrophe in January? Also, why are women so much less likely to take a vaccine? And how, exactly, does SARS-CoV-2 reach our brain?
Wait — is it four people? Or four households? And do children count as well? In Bonn, there's a fair amount of confusion as holiday lockdown rules come into effect. But with COVID-19 infections soaring, many Germans say their Christmas plans have already changed.
Just 51% of women to 69% of men — that's the staggering gender gap in COVID-19 vaccine willingness, according to a US survey. But how on earth did that happen? And how do we go about fixing it?
Which lessons should — and shouldn't — be drawn from the H1N1 immunization campaign of 2009? Are there anti-vax 'arguments' that really are worth debating? And which groups will be excluded from the first round(s) of COVID-19 vaccinations?
At this point it's clear that healthcare workers, the elderly or other at-risk groups should get vaccinations ASAP. But there are also people who, for reasons of health or medical ethics, should not.
We all know the coronavirus usually gets inside our bodies through the nose, the mouth or the eyes. But from there... how does it meander its way into our brain? New research from Berlin shows just how surprisingly direct the path is — and what happens when the virus gets there.
With Europe gearing up to vaccinate, people's willingness seems low — and is even going down in some countries. Why? In part, it's because people here remember what happened in 2009.
A dark milestone has been reached in Germany, with confirmed COVID-19 cases crossing the 1 million mark, as well as a record number of people dying this week. The government has extended the partial lockdown with apparently one thing in mind – saving Christmas.
What's the difference between a vaccine's efficacy and effectiveness? And how do the recent vaccine candidates from Moderna, AstraZeneca, Pfizer and BioNTech stack up compared to existing vaccines for polio, measles and other diseases?